ACADIA PHARMACEUTICALS INC.
-
Open
54.57
-
Previous Close
54.46
-
Volume (Avg)
756.06k (872.02k)
-
Day's Range
53.13-54.70
-
52Wk Range
30.02-58.72
-
Market Cap.
8.52B
-
Dividend Rate ( Yield)
-
-
Beta
1.24
-
Shares Outstanding
158.98M
-
P/E Ratio (EPS)
-
Top Stories
-
First Week of September 17th Options Trading For Acadia Pharmaceuticals (ACAD)
Nasdaq 1 day agoInvestors in Acadia Pharmaceuticals Inc (Symbol: ACAD) saw new options begin trading this week, for the September 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay,
-
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) President Srdjan R. Stankovic Sells 700 Shares
theenterpriseleader.com -
J.P. Morgan Believes ACADIA Pharmaceuticals (ACAD) Still Has Room to Grow
Smarter Analyst -
ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Stephen Davis at 39th Annual J.P. Morgan Healthcare Conference (Transcript)
Seeking Alpha -
Acadia Pharmaceuticals
The Motley Fool 2 days agoWhile everyone's focused on COVID-19, these drugmakers are looking forward to unrelated FDA approvals that could push their stock prices into the clouds. A strong Q1 performance set the tone, but ...
-
Insider Selling: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) President Sells 29,733 Shares of Stock
modernreaders.com -
ACADIA Pharmaceuticals Inc. to Post FY2020 Earnings of ($1.82) Per Share, Jefferies Financial Group Forecasts (NASDAQ:ACAD)
modernreaders.com -
Shuman Glenn & Stecker Investigates Acadia Pharmaceuticals, Inc.
MarketWatch -
ACADIA Pharmaceuticals Price to Book Value:
YCharts -
ACAD Dec 2020 51.000 put
Yahoo Finance -
ACAD Dec 2020 61.000 call
Yahoo Finance -
ACAD Jun 2021 43.000 call
Yahoo Finance -
ACAD Jan 2021 48.000 call
Yahoo Finance -
ACADIA Pharmaceuticals Inc
Bloomberg -
Shuman Glenn & Stecker Investigates Acadia Pharmaceuticals, Inc.
Morningstar%2c Inc. 5 days agoShuman Glenn & Stecker Investigates Acadia Pharmaceuticals, Inc. Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of ...
-
ACADIA Pharmaceuticals Inc ACAD
Morningstar%2c Inc. -
ACADIA Pharmaceuticals Price:
YCharts -
Shuman Glenn & Stecker Investigates Acadia Pharmaceuticals, Inc.
Benzinga.com
![image beacon](https://web.vortex.data.msn.com/collect/v1/t.gif?name=%27Ms.Webi.PageView%27&ver=%272.1%27&appId=%27JS%3AMSN%27&ext-app-env=%27prod%27&ext-javascript-libver=%274.0.0-beta-10%27&ext-user-localId=%27t%3A0FF74E5605C76F612CB7419404D56EEF%27&*baseType=%27Ms.Content.PageView%27&*isJs=False&*title=%27%27&*isLoggedIn=False&*isManual=True&*serverImpressionGuid=%270007a9d3-d15c-4cae-b495-6b5151c2868d%27&-ver=%271.0%27&-impressionGuid=%270007a9d3-d15c-4cae-b495-6b5151c2868d%27&-pageName=%27stocksummary%27&-uri=%27http%253A%252F%252Fwww.msn.com%252Fen-us%252Fmoney%252Fstockdetails%252Fnas-acad%252Ffi-a1mrrw%27&-referrerUri=%27%27&-pageTags=%27{"pg.t"%3A"data"%2C"pg.p"%3A"prime"%2C"pg.c"%3A""%2C"ex"%3A""%2C"rid"%3A"0007a9d3d15c4caeb4956b5151c2868d"%2C"clid"%3A"0FF74E5605C76F612CB7419404D56EEF"%2C"clidType"%3A"muid"%2C"di"%3A"7290"%2C"partner"%3A"Thomson%2BReuters"%2C"publcat"%3A"Thomson%2BReuters%252c%2BLLC"%2C"cvs"%3A"Browser"%2C"subcvs"%3A"finance"%2C"entityId"%3A"a1mrrw"%2C"entitySrc"%3A"fi"%2C"provid"%3A"AAf3a78"%2C"dpt"%3A"stockdetails"%2C"sdpt"%3A"nas-acad"%2C"ar"%3A"0"%2C"dgk"%3A"downlevel.pc"%2C"imd"%3A"0"%2C"parentId"%3A""%2C"pgIdx"%3A""%2C"pgTot"%3A""%2C"anoncknm"%3A""%2C"afd"%3A""%2C"issso"%3A"0"%2C"aadState"%3A"0"}%27&-behavior=0&-market=%27en-us%27){kind=small}